β-TrCP Inhibition Reduces Prostate Cancer Cell Growth via Upregulation of the Aryl Hydrocarbon Receptor

BACKGROUND: Prostate cancer is a common and heterogeneous disease, where androgen receptor (AR) signaling plays a pivotal role in development and progression. The initial treatment for advanced prostate cancer is suppression of androgen signaling. Later on, essentially all patients develop an androg...

Descripción completa

Detalles Bibliográficos
Autores principales: Gluschnaider, Udi, Hidas, Guy, Cojocaru, Gady, Yutkin, Vladimir, Ben-Neriah, Yinon, Pikarsky, Eli
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816705/
https://www.ncbi.nlm.nih.gov/pubmed/20140206
http://dx.doi.org/10.1371/journal.pone.0009060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816705/
https://www.ncbi.nlm.nih.gov/pubmed/20140206
http://dx.doi.org/10.1371/journal.pone.0009060

Ejemplares similares